Crescina Follicular Islands Re-Growth 2100 Hair-Loss Man Vials 20's
Crescina Follicular Islands Re-Growth 2100 Hair-Loss Man Vials 20's is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Overview: Crescina Hair Follicular Islands is a specialized topical cosmetic treatment designed to support hair growth and combat thinning. Available in ampoules, it features the patented Crescina Re-Growth formula, which includes key ingredients such as cysteine, lysine, and glycoproteins, and is integrated into a delivery system for gradual release. This formula is complemented by a unique complex of active ingredients to stimulate the growth of hair follicles.
Key Ingredients:
- Cysteine
- Lysine
- Glycoproteins
- Stem Engine - HFSC formula (including Cyclodextrins for controlled release)
-
Special Complex for Swiss Follicular Islands:
- Glycogen
- Glutamyl-amido-ethyl-indole
- Lupinus albus
- Proline
- Extracts of Triticum vulgare (Wheat), Glycine max (Soybean), and Scutellaria baicalensis (Baikal Skullcap)
Benefits:
- Supports Hair Growth: Aids in the physiological growth of hair by promoting the development of hair follicles.
- Targeted Action: Specifically helps primary and secondary bulbs and follicles within follicular islands.
- Not for Atrophied Follicles: Does not affect completely atrophied bulbs and follicles.
How to Apply:
- Initial Treatment: Apply one 3.5 ml ampoule per day for five consecutive days.
- Rest Period: Follow with a two-day rest period.
- Ongoing Use: Repeat the treatment cycle as per the instructions provided in the package.
- Package Size: Each package contains 20 ampoules, sufficient for one month of treatment.
FAQ:
- What is the duration of treatment? The recommended treatment period is at least two months.
- How often should I apply the ampoule? One ampoule daily for five consecutive days, followed by a two-day break, as per the instructions on the package.
- Is this treatment suitable for all types of hair loss? It is indicated for thinning of physiological and non-pathological origin but does not act on fully atrophied follicles.